keyword
https://read.qxmd.com/read/38616755/revolutionizing-neurological-disorder-treatment-integrating-innovations-in-pharmaceutical-interventions-and-advanced-therapeutic-technologies
#1
JOURNAL ARTICLE
Rimpi Arora, Ashish Baldi
Neurological disorders impose a significant burden on individuals, leading to disabilities and a reduced quality of life. However, recent years have witnessed remarkable advancements in pharmaceutical interventions aimed at treating these disorders. This review article aims to provide an overview of the latest innovations and breakthroughs in neurological disorder treatment, with a specific focus on key therapeutic areas such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke...
April 9, 2024: Current Pharmaceutical Design
https://read.qxmd.com/read/38604203/the-burden-of-neurological-conditions-in-north-africa-and-the-middle-east-1990-2019-a-systematic-analysis-of-the-global-burden-of-disease-study-2019
#2
JOURNAL ARTICLE
(no author information available yet)
BACKGROUND: The burden of neurological conditions in north Africa and the Middle East is increasing. We aimed to assess the changes in the burden of neurological conditions in this super-region to aid with future decision making. METHODS: In this analysis of the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 data, we examined temporal trends of disability-adjusted life-years (DALYs; deaths and disabilities combined), deaths, incident cases, and prevalent cases of 14 major neurological conditions and eight subtypes in 21 countries in the north Africa and the Middle East super-region...
April 8, 2024: Lancet Global Health
https://read.qxmd.com/read/38577947/mitochondrial-dysfunction-in-chronic-neuroinflammatory-diseases-review
#3
JOURNAL ARTICLE
Pei Qin, Ye Sun, Liya Li
Chronic neuroinflammation serves a key role in the onset and progression of neurodegenerative disorders. Mitochondria serve as central regulators of neuroinflammation. In addition to providing energy to cells, mitochondria also participate in the immunoinflammatory response of neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, multiple sclerosis and epilepsy, by regulating processes such as cell death and inflammasome activation. Under inflammatory conditions, mitochondrial oxidative stress, epigenetics, mitochondrial dynamics and calcium homeostasis imbalance may serve as underlying regulatory mechanisms for these diseases...
May 2024: International Journal of Molecular Medicine
https://read.qxmd.com/read/38562292/hub-overload-and-failure-as-a-final-common-pathway-in-neurological-brain-network-disorders
#4
REVIEW
Cornelis Jan Stam
Understanding the concept of network hubs and their role in brain disease is now rapidly becoming important for clinical neurology. Hub nodes in brain networks are areas highly connected to the rest of the brain, which handle a large part of all the network traffic. They also show high levels of neural activity and metabolism, which makes them vulnerable to many different types of pathology. The present review examines recent evidence for the prevalence and nature of hub involvement in a variety of neurological disorders, emphasizing common themes across different types of pathology...
2024: Network Neuroscience
https://read.qxmd.com/read/38547427/disease-modifying-treatments-for-multiple-sclerosis-affect-measures-of-cellular-immune-responses-to-ebna-1-peptides
#5
JOURNAL ARTICLE
Lara Dungan, Jean Dunne, Michael Savio, Marianna Kalaszi, Matt McElheron, Yvonne Lynagh, Kate O'Driscoll, Carmel Roche, Ammara Qureshi, Brendan Crowley, Niall Conlon, Hugh Kearney
BACKGROUND AND OBJECTIVES: Epstein-Barr virus (EBV) has been strongly implicated in the pathogenesis of multiple sclerosis (MS). Despite this, there are no routinely used tests to measure cellular response to EBV. In this study, we analyzed the cellular response to EBV nuclear antigen-1 (EBNA-1) in people with MS (pwMS) using a whole blood assay. METHODS: This cross-sectional study took place in a dedicated MS clinic in a university hospital. We recruited healthy controls, people with epilepsy (PWE), and pwMS taking a range of disease-modifying treatments (DMTs) including natalizumab, anti-CD20 monoclonal antibodies (mAbs), dimethyl fumarate (DMF), and also treatment naïve...
May 2024: Neurology® Neuroimmunology & Neuroinflammation
https://read.qxmd.com/read/38540392/the-genetics-of-tuberous-sclerosis-complex-and-related-mtoropathies-current-understanding-and-future-directions
#6
REVIEW
Alice Man, Matteo Di Scipio, Shan Grewal, Yujin Suk, Elisabetta Trinari, Resham Ejaz, Robyn Whitney
The mechanistic target of rapamycin (mTOR) pathway serves as a master regulator of cell growth, proliferation, and survival. Upregulation of the mTOR pathway has been shown to cause malformations of cortical development, medically refractory epilepsies, and neurodevelopmental disorders, collectively described as mTORopathies. Tuberous sclerosis complex (TSC) serves as the prototypical mTORopathy. Characterized by the development of benign tumors in multiple organs, pathogenic variants in TSC1 or TSC2 disrupt the TSC protein complex, a negative regulator of the mTOR pathway...
March 4, 2024: Genes
https://read.qxmd.com/read/38538647/genetic-causal-role-of-body-mass-index-in-multiple-neurological-diseases
#7
JOURNAL ARTICLE
Xie Wang, Hong Chen, Ze Chang, Juan Zhang, Daojun Xie
Body mass index (BMI) is a crucial health indicator for obesity. With the progression of socio-economic status and alterations in lifestyle, an increasing number of global populations are at risk of obesity. Given the complexity and severity of neurological diseases, early identification of risk factors is vital for the diagnosis and prognosis of such diseases. In this study, we employed Mendelian randomization (MR) analysis utilizing the most comprehensive genome-wide association study (GWAS) data to date...
March 27, 2024: Scientific Reports
https://read.qxmd.com/read/38525335/belief-in-omens-and-superstitions-among-patients-with-chronic-neurological-disorders
#8
JOURNAL ARTICLE
Rūta Mameniškienė, Rasa Kizlaitienė, Rūta Kaladytė Lokominienė, Kristijonas Puteikis
INTRODUCTION: Chronic neurological disorders may affect various cognitive processes, including religiosity or superstitious belief. We investigated whether superstitious beliefs are equally prevalent in patients with Parkinson's disease (PD), people with epilepsy (PWE), patients with multiple sclerosis (MS) and healthy controls (HCs). METHODS: From late 2014 to early 2023 we conducted a cross-sectional in-person anonymous paper-based survey at the tertiary clinic of Vilnius University Hospital Santaros Klinikos among outpatients and HCs by asking them to ascribe meaning or report belief for 27 culturally adapted statements (9 omens and 18 superstitions)...
2024: Frontiers in Public Health
https://read.qxmd.com/read/38507844/in-silico-exploration-of-cb2-receptor-agonist-in-the-management-of-neuroinflammatory-conditions-by-pharmacophore-modeling
#9
JOURNAL ARTICLE
Shlok Bodke, Nachiket Joshi, Rajasekhar Reddy Alavala, Divya Suares
Endocannabinoid system plays a pivotal role in controlling neuroinflammation, and modulating this system may not only aid in managing symptoms of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Multiple sclerosis, Epilepsy, Central and Peripheral neuropathic pain, but also, have the potential to target these diseases at an early-stage. In the present study, six different pharmacophore hypotheses were generated from Cannabidiol (CBD)-Cannabinoid Receptor subtype-2 (CB2) and then Zinc database was screened for identification of hit molecules...
March 10, 2024: Computational Biology and Chemistry
https://read.qxmd.com/read/38485124/racial-and-ethnic-disparities-in-neurological-care-in-the-united-states
#10
JOURNAL ARTICLE
Michael A Perez, Sahily Reyes-Esteves, Adys Mendizabal
The burden of neurological disease is increasing globally. In the United States, this burden is disproportionally greater for Black and Latino communities who have limited access to neurological care. Health services researchers have attempted to identify racial and ethnic disparities in neurological care and possible solutions. This article reviews the most current literature on racial and ethnic disparities in commonly encountered neurological conditions, including Stroke, Alzheimer's Disease, Multiple Sclerosis, Epilepsy, Parkinson's Disease, and Migraine...
March 14, 2024: Seminars in Neurology
https://read.qxmd.com/read/38485123/neurological-practice-in-the-time-of-war-perspectives-and-experiences-from-ukraine
#11
JOURNAL ARTICLE
Yuriy Flomin, Andriy Dubenko, Olga Dubenko, Larysa Sokolova, Tatyana Slobodin, Yevhen Shepotinnyk, Maryna Guliaieva, Francesca Romana Pezzella
The full-scale Russian invasion of Ukraine has significantly impacted the country's healthcare system. Insufficient infrastructure, destruction of medical facilities, and barriers to prevention and treatment efforts hinder the provision of timely, high-quality care to our patients. We aim to describe the impact of the war on neurological care across Ukraine. In this article, leading national experts in stroke, epilepsy, multiple sclerosis, and movement disorders describe their personal experience and efforts in organizing and providing care since the war started in February 2022...
March 14, 2024: Seminars in Neurology
https://read.qxmd.com/read/38477419/therapeutic-applicability-of-cannabidiol-and-other-phytocannabinoids-in-epilepsy-multiple-sclerosis-and-parkinson-s-disease-and-in-comorbidity-with-psychiatric-disorders
#12
REVIEW
Maria de Fátima Dos Santos Sampaio, Yara Bezerra de Paiva, Tuane Bazanella Sampaio, Messias Gonzaga Pereira, Norberto Cysne Coimbra
Studies have demonstrated the neuroprotective effect of cannabidiol (CBD) and other Cannabis sativa L. derivatives on diseases of the central nervous system caused by their direct or indirect interaction with endocannabinoid system-related receptors and other molecular targets, such as the 5-HT1A receptor, which is a potential pharmacological target of CBD. Interestingly, CBD binding with the 5-HT1A receptor may be suitable for the treatment of epilepsies, parkinsonian syndromes and amyotrophic lateral sclerosis, in which the 5-HT1A serotonergic receptor plays a key role...
March 13, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38468041/fractal-dimension-studies-of-the-brain-shape-in-aging-and-neurodegenerative-diseases
#13
JOURNAL ARTICLE
Jennilee M Davidson, Luduan Zhang, Guang H Yue, Antonio Di Ieva
The fractal dimension is a morphometric measure that has been used to investigate the changes of brain shape complexity in aging and neurodegenerative diseases. This chapter reviews fractal dimension studies in aging and neurodegenerative disorders in the literature. Research has shown that the fractal dimension of the left cerebral hemisphere increases until adolescence and then decreases with aging, while the fractal dimension of the right hemisphere continues to increase until adulthood. Studies in neurodegenerative diseases demonstrated a decline in the fractal dimension of the gray matter and white matter in Alzheimer's disease, amyotrophic lateral sclerosis, and spinocerebellar ataxia...
2024: Advances in Neurobiology
https://read.qxmd.com/read/38464610/the-cb1-cannabinoid-receptors-involvement-in-anti-epileptic-effect-of-safranal-on-penicillin-induced-epileptiform-activity-in-rats
#14
JOURNAL ARTICLE
Sina Tamaddonfard, Amir Erfanparast, Esmaeal Tamaddonfard, Farhad Soltanalinejad
Neuroprotective effects for natural products are supported by several studies. In this regard, safranal, a constitute of saffron, has the potential to exert beneficial effects in neuro-logical disorders such as Parkinson's disease, epilepsy, stroke, multiple sclerosis and Alzheimer's disease. Here, we investigated the effect of safranal on penicillin-induced epileptiform activity. Also, the effects of intracerebroventricular (ICV) microinjection of AM251 as a CB1-cannabinoid receptors antagonist to clarify the possible mechanism of safranal were evaluated...
2024: Veterinary Research Forum
https://read.qxmd.com/read/38452647/seizures-in-inflammatory-demyelinating-disorders-of-the-central-nervous-system
#15
JOURNAL ARTICLE
Özdem Ertürk Çetin, İpek Güngör Doğan, Ümit Zanapalioğlu, Feyzullah Yadi, Damla Çetinkaya Tezer, Serkan Demir
BACKGROUND: Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) may be associated with acute symptomatic seizures and chronic epilepsy as well. The clinical features of the seizures and/or accompanying epilepsy seen in each disease group may vary. In this study, we aimed to contribute to the existing literature by describing the clinical features of seizures and epilepsy in our demyelinating patient population...
March 3, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38433754/prenatal-diagnosis-and-clinical-management-of-cardiac-rhabdomyoma-a-single-center-study
#16
JOURNAL ARTICLE
Longzhuang Peng, Youchun Cai, Jianhang Wu, Wen Ling, Qiumei Wu, Shan Guo, Biying Huang, Caihong Jiang, Zongjie Weng
OBJECTIVE: The study aims to assess the ultrasonic features of fetal cardiac rhabdomyoma (CR), track the perinatal outcome and postnatal disease progression, investigate the clinical utility of ultrasound, MRI and tuberous sclerosis complex (TSC) gene analysis in CR evaluation, and offer evidence for determing of fetal CR prognosis. METHODS: We conducted a retrospective analysis of prenatal ultrasound-diagnosed fetal CR cases in our hospital from June 2011 to June 2022, tracked the perinatal outcomes, regularly followed live infants to analyze cardiac lesion changes and disease progression, and compared the sensitivities of ultrasound, MRI and their combination in the detecting of intracranial sclerosing nodules...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38428171/tuberous-sclerosis-complex-in-adulthood-focus-on-epilepsy-prognosis
#17
JOURNAL ARTICLE
Laura Licchetta, Giulia Bruschi, Carlotta Stipa, Laura Maria Beatrice Belotti, Lorenzo Ferri, Barbara Mostacci, Luca Vignatelli, Raffaella Minardi, Lidia Di Vito, Lorenzo Muccioli, Antonella Boni, Paolo Tinuper, Francesca Bisulli
OBJECTIVE: Typically diagnosed in early childhood or adolescence, TSC is a chronic, multisystemic disorder with age-dependent manifestations posing a challenge for transition and for specific surveillance throughout the lifetime. Data on the clinical features and severity of TSC in adults and on the prognosis of epilepsy are scarce. We analyzed the clinical and genetic features of a cohort of adult patients with TSC, to identify the prognostic predictors of seizure remission after a long follow-up...
February 29, 2024: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/38419734/prosopagnosia-face-blindness-and-its-association-with-neurological-disorders
#18
JOURNAL ARTICLE
Kennedy A Josephs, Keith A Josephs
Loss of facial recognition or prosopagnosia has been well-recognized for over a century. It has been categorized as developmental or acquired depending on whether the onset is in early childhood or beyond, and acquired cases can have degenerative or non-degenerative aetiologies. Prosopagnosia has been linked to involvement of the fusiform gyri, mainly in the right hemisphere. The literature on prosopagnosia comprises case reports and small case series. We aim to assess demographic, clinical and imaging characteristics and neurological and neuropathological disorders associated with a diagnosis of prosopagnosia in a large cohort...
2024: Brain communications
https://read.qxmd.com/read/38395126/microfluidics-as-diagnostic-tools
#19
REVIEW
Avanthika Satish Kumar, Sneha Venkatesalu, Shanmugapriya Dilliyappan, Ajay Prakash Pasupulla, Lavanya Prathap, Thirunavukkarasu Palaniyandi, Gomathy Baskar, Maddaly Ravi, Abimanyu Sugumaran
The challenges in the management of human diseases are largely determined by the precision, speed and ease of diagnostic procedures available. Developments in biomedical engineering technologies have greatly helped in transforming human health care, especially for disease diagnosis which in turn lead to better patient outcomes. One such development is in the form of microfluidic chip technology which has transformed various aspects of human health care. We present in this review, a comprehensive account on the utility of microfluidic chip technologies for the diagnosis of autoimmune disorders, cardiovascular diseases (CVDs), infectious diseases, and neurodegenerative conditions...
February 21, 2024: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://read.qxmd.com/read/38383156/incidence-and-determinants-of-seizures-in-multiple-sclerosis-a-meta-analysis-of-randomised-clinical-trials
#20
JOURNAL ARTICLE
Valeria Pozzilli, Shalom Haggiag, Massimiliano Di Filippo, Fioravante Capone, Vincenzo Di Lazzaro, Carla Tortorella, Claudio Gasperini, Luca Prosperini
BACKGROUND: Seizures are reported to be more prevalent in individuals with multiple sclerosis (MS) compared with the general population. Existing data predominantly originate from population-based studies, which introduce variability in methodologies and are vulnerable to selection and reporting biases. METHODS: This meta-analysis aims to assess the incidence of seizures in patients participating in randomised clinical trials and to identify potential contributing factors...
February 21, 2024: Journal of Neurology, Neurosurgery, and Psychiatry
keyword
keyword
165046
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.